Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 12, Pages 30144-30163
Publisher
MDPI AG
Online
2015-12-17
DOI
10.3390/ijms161226228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia
- (2015) Bonginkosi Chiliza et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis
- (2015) Yasunori Oda et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
- (2015) Masayuki Takase et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
- (2015) Tomotaka Suzuki et al. PSYCHIATRY RESEARCH
- Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
- (2014) Raquel Gomez-Sintes et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia
- (2014) Adam J. Funk et al. SCHIZOPHRENIA RESEARCH
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
- (2014) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association ofGSK-3βGenetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
- (2013) Giuseppe Blasi et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glycogen Synthase Kinase-3 Overexpression Replicates Electroretinogram Anomalies of Offspring at High Genetic Risk for Schizophrenia and Bipolar Disorder
- (2013) Joëlle Lavoie et al. BIOLOGICAL PSYCHIATRY
- Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese
- (2013) Wenxin Tang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis
- (2013) Hui Tang et al. MOLECULAR NEUROBIOLOGY
- Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression
- (2013) Y Kunii et al. MOLECULAR PSYCHIATRY
- Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease
- (2013) Roman Willi et al. NEUROPHARMACOLOGY
- Are dopamine D2 receptors out of control in psychosis?
- (2013) Philip Seeman PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- No association between AKT1 gene variants and schizophrenia: A Malaysian case-control study and meta-analysis
- (2013) Han Chern Loh et al. PSYCHIATRY RESEARCH
- Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression
- (2013) Robert E. Featherstone et al. PSYCHOPHARMACOLOGY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- The possible role of the Akt signaling pathway in schizophrenia
- (2012) Wenhua Zheng et al. BRAIN RESEARCH
- Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
- (2012) Ming-Huan Chan et al. SCHIZOPHRENIA RESEARCH
- AKT/GSK3 signaling pathway and schizophrenia
- (2012) Effat S. Emamian Frontiers in Molecular Neuroscience
- Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
- (2011) K O Schubert et al. MOLECULAR PSYCHIATRY
- Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder
- (2011) E.R. Bychkov et al. NEUROBIOLOGY OF DISEASE
- CALM, A Clathrin Assembly Protein, Influences Cell Surface GluR2 Abundance
- (2011) Asaff Harel et al. NEUROMOLECULAR MEDICINE
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
- (2011) J. A. Allen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility
- (2011) Ming Li et al. SCHIZOPHRENIA RESEARCH
- Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia
- (2011) Terence K.Y. Lai et al. SYNAPSE
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reconnaître les symptômes psychiatriques iatrogènes liés aux antipsychotiques
- (2010) C. Demily et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
- (2010) Paul Fallon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics
- (2010) Y.W. Chen et al. NEUROSCIENCE
- GSK-3β activity and hyperdopamine-dependent behaviors
- (2010) Yan-Chun Li et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease
- (2010) M. R. Ahmed et al. Science Translational Medicine
- Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia
- (2010) Sheng Chen et al. SYNAPSE
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- The coding-synonymous polymorphism rs1045280 (Ser280Ser) inβ-arrestin 2(ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia
- (2008) Y.-J. Liou et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
- (2008) Ariel Graff-Guerrero et al. NEUROPSYCHOPHARMACOLOGY
- Physiological and pharmacological implications of beta-arrestin regulation
- (2008) Cullen L. Schmid et al. PHARMACOLOGY & THERAPEUTICS
- Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
- (2008) Renan P. Souza et al. PSYCHOPHARMACOLOGY
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Course of illness in a sample of 265 patients with first-episode psychosis—Five-year follow-up of the Danish OPUS trial
- (2008) Mette Bertelsen et al. SCHIZOPHRENIA RESEARCH
- Dopamine D2High receptors moderately elevated by sertindole
- (2008) Philip Seeman SYNAPSE
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
- (2007) Dawn L. Thiselton et al. BIOLOGICAL PSYCHIATRY
- Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder
- (2007) Akira Yoshimi et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now